COMMUNIQUÉS West-GlobeNewswire

Equillium to Host Business Update Call on February 26

19/02/2019 - 22:07

LA JOLLA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, will be hosting a call with shareholders and the [...]

Alder BioPharmaceuticals® to Host Conference Call to Discuss Fourth Quarter and Year-End 2018 Financial and Operating Results

19/02/2019 - 22:05

BOTHELL, Wash., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Harvard Bioscience Schedules Fourth Quarter 2018 Conference Call for February 28 at 4:30 PM ET

19/02/2019 - 22:05

HOLLISTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for [...]

Rubius Therapeutics to Participate at Upcoming Investor Conferences

19/02/2019 - 22:05

CAMBRIDGE, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biopharmaceutical company that is generating red blood cells and bioengineering them into an entirely new class of cellular [...]

Corcept Therapeutics To Announce Audited Financial Results, Provide Corporate Update And Host Conference Call

19/02/2019 - 22:05

MENLO PARK, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report its audited 2018 fourth quarter and full-year financial results and provide a [...]

LeMaitre Vascular Announces Q4 2018 Financial Results

19/02/2019 - 22:05

BURLINGTON, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q4 2018 results, provided guidance, announced a 21% [...]

Ovid Therapeutics Announces Proposed Concurrent Public Offerings of Common Stock and Preferred Stock

19/02/2019 - 22:01

NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]

Dermira to Report Fourth Quarter 2018 Results and Host Conference Call on Tuesday, February 26, 2019

19/02/2019 - 22:01

MENLO PARK, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Sientra to Present at the 8th Annual SVB Leerink Global Healthcare Conference

19/02/2019 - 22:01

SANTA BARBARA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the 8 th Annual SVB Leerink [...]

Ultragenyx Reports Fourth Quarter and Full Year 2018 Financial Results and Corporate Update

19/02/2019 - 22:01

Strong Launch Continues With More than 550 Patients on Reimbursed Commercial Crysvita® (burosumab) Therapy in the United States at End of 4th Quarter 2018, 80 Percent Increase Versus End of 3rd Quarter NOVATO, Calif., [...]

Innodem Neurosciences Receives 1 Million Dollars in Funding to Give a Voice to Voiceless Patients

19/02/2019 - 21:49

MONTREAL, Feb. 19, 2019 (GLOBE NEWSWIRE) -- CENTECH’s Innodem Neurosciences, a Montreal-based start-up that spun-out of McGill University’s Montreal Neurological Institute and Hospital (The NEURO) less than one year ago [...]

Innodem Neurosciences reçoit un million de dollars de financement afin de donner une voix aux patients privés de la parole

19/02/2019 - 21:49

MONTRÉAL, 19 févr. 2019 (GLOBE NEWSWIRE) -- Innodem Neurosciences, jeune entreprise issue de l’Institut et hôpital neurologique de Montréal (Le Neuro) de l’Université McGill et membre de l’incubateur CENTECH, a mis au [...]

Dr. Kiran Patel of The Spine & Pain Institute of New York Joins NANS Board

19/02/2019 - 21:46

NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- The Spine & Pain Institute of New York congratulates Dr. Kiran V. Patel for her recent and first appointment to the Board of Directors of NANS, for a two-year term. Dr. [...]

NM Medical Cannabis Inadequate Supply Points to Public Health Crisis

19/02/2019 - 20:03

NMDOH data indicates Q4 2018 in-stock cannabis supply at half of reported levels in 2017 ALBUQUERQUE, N.M., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Data regarding New Mexico’s Medical Cannabis Program activity released by the [...]

Novo Nordisk receives US FDA approval of ESPEROCT® (turoctocog alfa pegol, N8-GP)

19/02/2019 - 18:30

Bagsværd, Denmark, 19 February 2019 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application for ESPEROCT ® for the treatment of adults and children [...]

Néovacs : Agenda financier 2019

19/02/2019 - 18:30

COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE AGENDA FINANCIER 2019 Paris et Boston, le 19 février 2019 – NÉOVACS (Euronext Growth Paris : ALNEV), leader de l’immunothérapie active pour le [...]

Westleaf: A Truly Vertically-Integrated Cannabis Play -- CFN Media

19/02/2019 - 18:20

SEATTLE, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

National Brain Tumor Society and the Brain Science Foundation Partner to Fund Research for Most Common Brain Tumor Type

19/02/2019 - 18:12

Brain tumor nonprofits establish the Meningioma Research Fund to seek a cure and help thousands across the country Boston, MA, Feb. 19, 2019 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), a leading nonprofit [...]

Canadian Startup Enhanced Medical Nutrition (“EMN”) Completes Oversubscribed Seed Round Funding

19/02/2019 - 18:00

NOT FOR DISTRIBUTION IN THE UNITED STATES Toronto, Ontario, Feb. 19, 2019 (GLOBE NEWSWIRE) -- EMN, a Canadian medical nutrition company, has raised a $1.2 Million seed round led by several prominent angel investors from [...]